Impact of HCV protease-inhibitor-based triple therapy for chronic HCV genotype 1 infection

2011 ◽  
Vol 16 (8) ◽  
pp. 1187-1201 ◽  
Author(s):  
Peter Ferenci ◽  
K Rajender Reddy
Keyword(s):  
Protease Inhibitor ◽  
Triple Therapy ◽  
Genotype 1 ◽  
Hcv Genotype ◽  
Hcv Protease ◽  
Hcv Genotype 1 ◽  
Chronic Hcv

Potency, safety, and pharmacokinetics of the NS3/4A protease inhibitor BI201335 in patients with chronic HCV genotype-1 infection

2011 ◽  
Vol 54 (6) ◽  
pp. 1114-1122 ◽  
Author(s):  
Michael P. Manns ◽  
Marc Bourlière ◽  
Yves Benhamou ◽  
Stanislas Pol ◽  
Maurizio Bonacini ◽  
...  
Keyword(s):  
Protease Inhibitor ◽  
Genotype 1 ◽  
Hcv Genotype ◽  
Hcv Genotype 1 ◽  
Chronic Hcv

P1172 “REAL-LIFE”-EXPERIENCE WITH PROTEASE INHIBITOR-TRIPLE THERAPY IN HCV GENOTYPE 1 (G1) PATIENTS (N = 131): SVR 24 RESULTS

2014 ◽  
Vol 60 (1) ◽  
pp. S475
Author(s):  
C.R. Werner ◽  
C. Franz ◽  
D.P. Egetemeyr ◽  
N.P. Malek ◽  
U.M. Lauer ◽  
...  
Keyword(s):  
Protease Inhibitor ◽  
Triple Therapy ◽  
Life Experience ◽  
Real Life ◽  
Genotype 1 ◽  
Hcv Genotype ◽  
Hcv Genotype 1

Baseline prevalence and emergence of protease inhibitor resistance mutations following treatment in chronic HCV genotype 1-infected individuals

2015 ◽  
Vol 20 (8) ◽  
pp. 865-869 ◽  
Author(s):  
Linh Thuy Nguyen ◽  
Emma Gray ◽  
Jonathan Dean ◽  
Michael Carr ◽  
Jeff Connell ◽  
...  
Keyword(s):  
Protease Inhibitor ◽  
Genotype 1 ◽  
Resistance Mutations ◽  
Hcv Genotype ◽  
Protease Inhibitor Resistance ◽  
Hcv Genotype 1 ◽  
Chronic Hcv ◽  
Inhibitor Resistance
Sign in / Sign up

Export Citation Format

Share Document